Tag Archive for: bone metastases
Sn-117m-DTPA Emerges as Theranostic: Phase 1/2 Trials
/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by MaxCOMRADE Phase 2 Trial Initial Results: Combination of Olaparib and Radium-223 Shows Promise in Extending Progression-Free Survival
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxScientists Uncover Key Protein Driving Cancer Spread to Bone, ASH1L
/0 Comments/in CRISPR, Preclinical Research/by MaxASH1
ACBP: Scientists Identify Key Protein Driving Bone Metastasis, Pointing to New Therapeutic Strategies
/0 Comments/in CRISPR, Preclinical Research/by MaxPT-112: FDA Clears Phase 3 Trial of Novel Therapy for Advanced Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 3/by MaxBTE-EN1: Some Hope For Prostate Cancer Patients with Bone Metastasis
/0 Comments/in Preclinical Research/by MaxPhase 1: China Approves Groundbreaking Drug for Bone Metastases SKB107
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxA New Wave in Bone Grafting: Coral-Inspired Material Offers Hope for Faster Healing
/0 Comments/in Preclinical Research/by MaxA Phase 1 trial to keep an eye on: Thorium-227 (BAY2315497) in metastatic Castration Resistant Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA MYC NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data theranostics
Latest Posts
- Anti-PD-L1 Therapy Shows Promise for MMR-Deficient Metastatic Prostate Cancer August 30, 2025
- Phase 2 Trial: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response via Modulation of Androgen Receptor (SPIDERMAN) August 29, 2025
- Phase 1: AMG 509 (Xaluritamig) for Metastatic Hormone Sensitive Prostate Cancer August 29, 2025
- Phase 1: Lartesertib and Tuvusertib Target DNA Repair to Fight Resistant Tumors August 29, 2025